Cutaneous leishmaniasis treatment and therapeutic outcomes in special populations: A collaborative retrospective study

Abstract

Our findings support the need for greater availability and use of alternatives to systemic antimonials, particularly local therapies, and development of strategies to improve patient follow-up across the region, with special attention to pediatric populations.